Exposure to MF59-adjuvanted influenza vaccines during pregnancy--a retrospective analysis. (Q30383270)

21 June 2017

Exposure to MF59-adjuvanted influenza vaccines during pregnancy--a retrospective analysis. (English)

1 reference

21 June 2017

1 reference

Theodore Tsai

1

1 reference

21 June 2017

Moe H Kyaw

2

1 reference

21 June 2017

Deborah Novicki

3

1 reference

21 June 2017

Pantaleo Nacci

4

1 reference

21 June 2017

Saroj Rai

5

1 reference

21 June 2017

Ralf Clemens

6

1 reference

21 June 2017

language of work or name

English

0 references

publication date

5 December 2009

1 reference

21 June 2017

1 reference

21 June 2017

28

1 reference

21 June 2017

7

1 reference

21 June 2017

1877-1880

1 reference

Influenza vaccination in pregnancy: current evidence and selected national policies.

21 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.077

Is routine influenza immunization warranted in early pregnancy?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.077

Community influenza activity and risk of acute influenza-like illness episodes among healthy unvaccinated pregnant and postpartum women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.077

Impact of influenza on acute cardiopulmonary hospitalizations in pregnant women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.077

Maternal morbidity and perinatal outcomes among pregnant women with respiratory hospitalizations during influenza season.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.077

H1N1 2009 influenza virus infection during pregnancy in the USA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.077

Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.077

Dose ranging of adjuvant and antigen in a cell culture H5N1 influenza vaccine: safety and immunogenicity of a phase 1/2 clinical trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.077

7 January 2021

Safety of MF59 adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.077

Safety of influenza vaccination during pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.077

Effectiveness of influenza vaccine during pregnancy in preventing hospitalizations and outpatient visits for respiratory illness in pregnant women and their infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.077

Impact of maternal influenza vaccination during pregnancy on the incidence of acute respiratory illness visits among infants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.077

Effectiveness of maternal influenza immunization in mothers and infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.077

Safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine for cervical cancer prevention: a pooled analysis of 11 clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.077

The transmissibility and control of pandemic influenza A (H1N1) virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.077

10.1016/J.VACCINE.2009.11.077

7 January 2021

Identifiers

DOI

1 reference

release_xbwigumpp5cstctn4waqzz327e

21 June 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/xbwigumpp5cstctn4waqzz327e

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference